Renin–Angiotensin–Aldosterone System and Immunomodulation: A State-of-the-Art Review

• Published in: Cells (Basel, Switzerland) Vol. 10; no. 7; p. 1767
• Main Authors: Laghlam, Driss, Jozwiak, Mathieu, Nguyen, Lee S.
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 13.07.2021; MDPI
• Subjects: Aldosterone; Angiogenesis; Angiotensin; Angiotensin II; Antihypertensives; Apoptosis; Blood pressure; Cell growth; Cell migration; Cell proliferation; Cell survival; Diabetes; Disease; Enzymes; Fibrosis; Glucose; Graft rejection; Homeostasis; Hypertension; Immunomodulation; Inflammation; Insulin resistance; Kidneys; Kinases; Liver; Lymphocytes; Metabolic disorders; Metabolic syndrome; Neutrophils; oncology; Oxidative stress; Peptides; Physiology; Proteins; Renin; renin–angiotensin system; Review; shock; Signal transduction; Transplantation
• ISSN: 2073-4409; 2073-4409
• DOI: 10.3390/cells10071767

The renin–angiotensin system (RAS) has long been described in the field of cardiovascular physiology as the main player in blood pressure homeostasis. However, other effects have since been described, and include proliferation, fibrosis, and inflammation. To illustrate the immunomodulatory properties of the RAS, we chose three distinct fields in which RAS may play a critical role and be the subject of specific treatments. In oncology, RAS hyperactivation has been associated with tumor migration, survival, cell proliferation, and angiogenesis; preliminary data showed promise of the benefit of RAS blockers in patients treated for certain types of cancer. In intensive care medicine, vasoplegic shock has been associated with severe macro- and microcirculatory imbalance. A relative insufficiency in angiotensin II (AngII) was associated to lethal outcomes and synthetic AngII has been suggested as a specific treatment in these cases. Finally, in solid organ transplantation, both AngI and AngII have been associated with increased rejection events, with a regional specificity in the RAS activity. These elements emphasize the complexity of the direct and indirect interactions of RAS with immunomodulatory pathways and warrant further research in the field.